US 8697082
Prevention and treatment of synucleinopathic and amyloidogenic disease
granted A61KA61K2039/505A61K38/1709
Quick answer
US patent 8697082 (Prevention and treatment of synucleinopathic and amyloidogenic disease) held by The Regents of the University of California expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61K38/1709, A61K39/0007